Vimarsana
Biggest News Aggregation in the World

Nasdaq Meip News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Meip. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Meip Today - Breaking & Trending Today

MEI Pharma (NASDAQ:MEIP) Coverage Initiated at StockNews.com - Vimarsana News

MEI Pharma (NASDAQ:MEIP) Coverage Initiated at StockNews.com

Analysts at StockNews.com began coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a report issued on Tuesday. The brokerage set a “buy” rating on the stock. Other equities analysts have also issued research reports about the company. TheStreet lowered MEI Pharma from a “c-” rating to a “d+” rating in a […]

MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com - Vimarsana News

MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a note issued to investors on Monday. The firm set a “buy” rating on the stock. A number of other equities analysts have also recently issued reports on MEIP. Stifel Nicolaus reiterated a “hold” rating and issued a $7.00 price target […]

Source: wkrb13.com
MEI Pharma (NASDAQ:MEIP) Price Target Cut to $7.00 by Analysts at Stifel Nicolaus - Vimarsana News

MEI Pharma (NASDAQ:MEIP) Price Target Cut to $7.00 by Analysts at Stifel Nicolaus

MEI Pharma (NASDAQ:MEIP – Free Report) had its price objective trimmed by Stifel Nicolaus from $8.00 to $7.00 in a research note issued to investors on Wednesday morning, Benzinga reports. The firm currently has a hold rating on the stock. MEIP has been the topic of a number of other reports. StockNews.com downgraded shares of […]

Source: wkrb13.com
Investment Analysts' Weekly Ratings Changes for MEI Pharma (MEIP) - Vimarsana News

Investment Analysts' Weekly Ratings Changes for MEI Pharma (MEIP)

Several analysts have recently updated their ratings and price targets for MEI Pharma (NASDAQ: MEIP): 2/14/2024 – MEI Pharma had its price target lowered by analysts at Stifel Nicolaus from $8.00 to $7.00. They now have a “hold” rating on the stock. 2/13/2024 – MEI Pharma was downgraded by analysts at StockNews.com from a “buy” […]

StockNews.com Begins Coverage on MEI Pharma (NASDAQ:MEIP) - Vimarsana News

StockNews.com Begins Coverage on MEI Pharma (NASDAQ:MEIP)

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Sunday morning. The firm issued a hold rating on the stock. Separately, TheStreet raised MEI Pharma from a d- rating to a c- rating in a report on Friday, November 17th. One investment analyst has rated the stock […]